Ovarian cancer in the elderly: Impact of surgery on morbidity and survival

被引:24
作者
Chereau, E. [1 ]
Ballester, M.
Selle, F. [2 ]
Rouzier, R.
Darai, E.
机构
[1] Univ Paris 06, Hop Tenon, AP HP, Dept Gynecol Obstet,Serv Gynecol Obstet, F-75020 Paris, France
[2] Univ Paris 06, Hop Tenon, AP HP, Dept Med Oncol, F-75020 Paris, France
来源
EJSO | 2011年 / 37卷 / 06期
关键词
Ovarian cancer; Elderly; Optimal surgery; Morbidity; Outcome; LYMPH-NODE RESECTION; EPITHELIAL OVARIAN; CYTOREDUCTIVE SURGERY; NEOADJUVANT CHEMOTHERAPY; CARCINOMA; MANAGEMENT; OUTCOMES; WOMEN; OLDER; AGE;
D O I
10.1016/j.ejso.2011.03.136
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Elderly ovarian cancer patients often undergo non-optimal surgery due to their age despite of the high risk of recurrence. The aim of this study was to determine if more postoperative complications occurred in patients over 70 years and to compare extent of surgery with younger patients. Materials and methods: Between 2001 and 2009, 172 patients with ovarian cancer were included. We compared patient characteristics, surgical course, postoperative complications and outcome for patients under and over 70 years. Results: 143 patients were under 70 years and 29 over. There were no difference between the two groups for tumors characteristics, time of surgery, FIGO stage, standard surgical procedures and rate of optimal resection. Patients over 70 years had less peritoneal surgery (p < 0.001) especially diaphragmatic surgery (p = 0.006), pelvic (p = 0.02) and para-aortic (p = 0.003) lymphadenectomy. There was no difference in the occurrence of per- or post-operative complications and patients over 70 years had shorter duration of hospitalization (p = 0.04). There was no difference between the two groups for disease-free survival (DFS) (p = 0.08) but overall survival (OS) was better in patients under 70 years (p = 0.002). Conclusion: Elderly ovarian cancer patients undergo less extensive surgery and have lower OS despite similar postoperative morbidity, optimal resection and DFS. OS decrease could be explained by difference in the management of recurrences. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:537 / 542
页数:6
相关论文
共 24 条
[1]   Ovarian cancer surgical resectability: Relative impact of disease, patient status, and surgeon [J].
Aletti, GD ;
Gostout, BS ;
Podratz, KC ;
Cliby, WA .
GYNECOLOGIC ONCOLOGY, 2006, 100 (01) :33-37
[2]   Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer [J].
Aletti, Giovanni D. ;
Dowdy, Sean C. ;
Podratz, Karl C. ;
Cliby, William A. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) :676.e1-676.e7
[3]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[4]   Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy [J].
Brun, Jean-Luc ;
Rouzier, Roman ;
Selle, Frederic ;
Houry, Sidney ;
Uzan, Serge ;
Darai, Emile .
BMC CANCER, 2009, 9
[5]   The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13,918 patients [J].
Chan, J. K. ;
Urban, R. ;
Hu, J. M. ;
Shin, J. Y. ;
Husain, A. ;
Teng, N. N. ;
Berek, J. S. ;
Osann, K. ;
Kapp, D. S. .
BRITISH JOURNAL OF CANCER, 2007, 96 (12) :1817-1822
[6]   Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer [J].
Chereau, Elisabeth ;
Ballester, Marcos ;
Selle, Frederic ;
Cortez, Annie ;
Darai, Emile ;
Rouzier, Roman .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 202 (02) :178.e1-178.e10
[7]   What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? [J].
Chi, D. S. ;
Eisenhauer, E. L. ;
Lang, J. ;
Huh, J. ;
Haddad, L. ;
Abu-Rustum, N. R. ;
Sonoda, Y. ;
Levine, D. A. ;
Hensley, M. ;
Barakat, R. R. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :559-564
[8]   Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma [J].
Chi, Dennis S. ;
Palayekar, Meena J. ;
Sonoda, Yukio ;
Abu-RuStum, Nadeern R. ;
Awtrey, Christopher S. ;
Huh, Jae ;
Eisenhauer, Eric L. ;
Barakat, Richard R. ;
Kattan, Michael W. .
GYNECOLOGIC ONCOLOGY, 2008, 108 (01) :191-194
[9]   Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach [J].
Chi, DS ;
Franklin, CC ;
Levine, DA ;
Akselrod, F ;
Sabbatini, P ;
Jarnagin, WR ;
DeMatteo, R ;
Poynor, EA ;
Abu-Rustum, NR ;
Barakat, RR .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :650-654
[10]   Management of ovarian cancer in patients older than 80 years of age [J].
Cloven, NG ;
Manetta, A ;
Berman, ML ;
Kohler, MF ;
DiSaia, PJ .
GYNECOLOGIC ONCOLOGY, 1999, 73 (01) :137-139